Latest news with #IVDD
The Sun
2 days ago
- Business
- The Sun
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited( - Forward-looking layout of the historical opportunity of the US 'Genius Act', the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA! In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited( took the lead in building the 'NewCo+RWA' Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin 'IVDDollar' (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation assets. On July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive stage. This strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion model. 1. Strategic opportunities under global regulatory resonance On July 18, 2025, local time, US President Trump signed the 'Guidance and Establishment of the United States Stablecoin National Innovation Act' (hereinafter referred to as the 'Genius Act') at the White House, establishing the legal status of stablecoins as 'digital dollars'. The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin market. The report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the 'Hong Kong + US' dual hub compliance architecture layout. The strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the 'Genius Act' for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong 'Stablecoin Ordinance' to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the 'Hong Kong Stock Stablecoin Concept Sector'. 2. Technological Innovation: 'NewCo+RWA+Stablecoin' Reconstructs the Value Chain of Medical Innovative Drug Assets The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology: 1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets; 2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's '1:1 redeemable' requirements; 3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of 'digital assets + traditional equity' to attract two-way inflows of traditional medical capital and crypto-native funds. The implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional investment. 3. Ecological synergy: creating a new paradigm for medical finance The Group's strategic advancement has always followed the three-dimensional path of 'regulatory compliance-technological innovation-ecological synergy'. In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license application. More importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and traceable. 4. Industry Impact and Future Outlook The Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of 'NewCo+RWA+stablecoin'. Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and investors.
Newsweek
04-07-2025
- Health
- Newsweek
Paralyzed Dachshund Tries Running with Brother, His Efforts Melts Hearts
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. When dachshund Monty lost the use of his legs aged six, he didn't let it slow him down. Now seven, Monty has gained viral attention for the way he rides in a dog-sized stroller alongside his brother Charlie. While Charlie runs ahead, Monty springs upright on his front legs, enthusiastically bouncing as if he's racing too. Owner Amy, 42, from Canada, told Newsweek that Monty's signature hop is nothing new. "He's always danced on his front feet—even when you bring him a water dish," she said. "Now when we go for walks in the stroller, he gets even more animated. If his brother or sister runs ahead, it amps him up." Monty and Charlie on one of their walks, where Monty doesn't let his paralysis slow him down. Monty and Charlie on one of their walks, where Monty doesn't let his paralysis slow him down. @amqzak/TikTok Monty was diagnosed with Intervertebral Disc Disease (IVDD) last year, a condition that commonly affects dachshunds because of their elongated spines. After undergoing treatment that included medication, acupuncture, and ten weeks of crate rest, Monty didn't regain mobility. But his personality has never changed. Read more Woman defends "hardest decision" to euthanize dog over behavior Woman defends "hardest decision" to euthanize dog over behavior "It was devastating," Amy said, reflecting on his sudden paralysis. "He was a healthy, happy boy. But how he's handled these circumstances has made it so much easier—as his mom, I just had to share his joy." IVDD is a degenerative condition that damages the discs cushioning the vertebrae and can lead to stiffness, weakness, or full paralysis. Dachshunds are particularly at-risk of IVDD, but so are other breeds like French bulldogs, beagles, cocker spaniels and Welsh corgis to name a few. Veterinarians urge owners to take proactive measures to prevent IVDD, including helping dogs maintain a healthy weight, avoid jumping on furniture or stairs and using proper support when lifting dogs. After Monty's diagnosis, Amy came up with the perfect solution to ensure he never misses out, with his trusty stroller helping him and his brother enjoy outings together. In a video caption sharing one of the pair's adventures, which amassed more than 900,000 views since being shared earlier this week, Amy said: "Despite being paralyzed, Monty is confident he is going to beat Charlie to the finish line. It's all in your mindset." "He hasn't lost his spirit. If anything," she said, "he's bouncing more than ever." Monty isn't the first dog with IVDD to captures the internet's heart. In 2024, another dog owner shared how their Labrador Bo suffered IVDD after a fall. While specialists were able to help him to walk again, he still sometimes needs reminding that he can move. In a heartwarming video, the owner shared how she sometimes had to remind her pup he can walk. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Newsweek
13-06-2025
- Entertainment
- Newsweek
Woman Can't Cope After Seeing What Cleaner Did to Dog's Steps: 'Excuse Me?'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The internet was in stitches at a tiny dog's reaction to the cleaner moving a very important piece of furniture. Willie Nelson, aka Willie the dachshund, lives in Colorado with his owner Piet Dayney, 29, who describes the one-year-old pup as "the sweetest" dog "with so much personality." Thanks to his small size—the breed has an average height of just nine inches, according to the American Kennel Club (AKC)—Dayney has made changes to her home to ensure he can get everywhere easily. This includes a special ramp or stairs that helps Willie climb up on the sofa to cuddle with his owner whenever he likes, with Dayney explaining: "We always use stairs for him since dachshunds are prone to intervertebral disc disease (IVDD), a back issue, so he's used to them." Piet Dayney notices her dachshund, Willie, staring her down. Piet Dayney notices her dachshund, Willie, staring her down. TikTok @its_williethecoween But when Dayney hired a cleaner to spruce up the home, Willie was left outraged when his special stairs suddenly led to nowhere. In a video to her TikTok account, @its_willithecoween on April 15, viewed more than 1.4 million times, Dayney showed Willie standing up, making intense eye contact with her. As she moved closer, it was revealed Willie was standing on his special stairs, but it had been moved to the side of the sofa, leading nowhere, and making him unable to jump up on the furniture. "When our cleaner forgot to put his couch stairs back," Dayney wrote over the video, alongside the caption: "Ummm... excuse me? Couch please?" She explained to Newsweek: "I just walked in on him being baffled he couldn't make it up to his napping spot since they weren't in their usual space. "He clearly made eye contact to tell me he was ready for them to move!" TikTok users loved it, awarding the video more than 90,000 likes, as one commenter wrote: "Not the stairs to nowhere." "I'm not arriving where this usually takes me," another joked. Willie stands on his stairs, which are leading to nowhere after the cleaner moved them away from the sofa. Willie stands on his stairs, which are leading to nowhere after the cleaner moved them away from the sofa. TikTok @its_williethecoween Others shared their own stories, one recalling moving their dog's stairs to vacuum, and their pet "ran up to them and right off the end like a cartoon character. Poor girl was shocked." "I moved our ramp to clean the floor and forgot to put it back. The oldest dachshund barked and I walked in to all 5 lined up on the ramp to no where," another laughed. Stairs or a ramp for dogs can be beneficial for multiple reasons, including for senior or arthritic dogs, small dogs, and breeds prone to back issues, including dachshunds who can develop IVDD, where changes occur to the protective material around the spinal cord, according to the AKC. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend and they could appear in our Pet of the Week lineup.
Yahoo
08-05-2025
- Business
- Yahoo
ALPCO Announces the European Commercial Launch of FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay and Patient Enrollment in Pivotal US Clinical Trial for Automated Chemiluminescent Version
SALEM, N.H., May 8, 2025 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, announced the European commercial launch of its Calprotectin Immunoturbidimetric Assay, expanding its portfolio of gastrointestinal (GI) diagnostic solutions globally. The assay, which received FDA 510(k) clearance in 2023 and IVDD certification in 2022, is intended for in vitro diagnostic use to aid in the diagnosis of inflammatory bowel disease (IBD)—including Crohn's disease (CD) and ulcerative colitis (UC)—and to help differentiate IBD from irritable bowel syndrome (IBS) when used alongside other clinical and laboratory findings. With a clinical sensitivity of 90.5% and specificity of 93.4%, the test offers high diagnostic accuracy and a low false positive rate. This enables healthcare providers to efficiently prioritize patients for colonoscopy, supporting faster diagnoses and more targeted care decisions. In addition to expanding its offerings to the European market, ALPCO confirmed the first patient enrolled in its pivotal clinical trial for US FDA clearance of an automated chemiluminescent version of ALPCO's leading calprotectin assay, designed for use on the KleeYa™ system. ALPCO completed the FDA pre-submission process in March 2025, with clinical trial enrollment beginning in April. The company's calprotectin assays have been integral to ALPCO's success in the GI market and the chemiluminescent platform represents a significant advancement in automation, aiming to provide clinical laboratories with a streamlined, efficient, and scalable solution for calprotectin testing. "We're thrilled to deliver a high-throughput GI test that is compatible with existing clinical chemistry analyzers while preserving accurate differentiation between IBD and IBS," said Erik Allen, CEO of ALPCO (A NuvinkaDx company). "In parallel, we're advancing our mission to deliver GI diagnostic solutions with greater automation and accuracy to clinical labs in the US." This dual milestone—the European launch and the start of the pivotal US trial—underscores ALPCO's commitment to innovation and leadership in GI diagnostics. About ALPCO and NuvinkaDx ALPCO was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life science markets. The company has since evolved into a leading producer of novel immunodiagnostic reagents for specialty testing laboratories. In 2022, ALPCO merged with GeneProof, a Czech Republic-based provider of specialty molecular diagnostic solutions. Founded in 2005, GeneProof offers a portfolio of more than 50 IVDD and 6 IVDR PCR test kits for infectious diseases and genetic mutations, as well as a suite of proprietary instrumentation for clinical laboratories of all sizes. In 2024 the holdings company for both organizations rebranded to NuvinkaDx. For additional information, please visit and View original content to download multimedia: SOURCE ALPCO
Yahoo
07-04-2025
- Health
- Yahoo
Dachshund's Happy Prance While Using Wheelchair for First Time Is the Cutest Thing We've Ever Seen
It's never easy watching your pet heal from an injury, and sometimes, the journey back to health takes longer than planned. During the stress of it all, time seems to slow down while you find new ways to comfort your baby. Oliver the Dachshund is healing from a disc-related disease that has him spending a lot of time resting. But now that he's getting better, his new wheelchair lets him see the world again, and he couldn't be more grateful. To fully appreciate the Dachshund's gleeful stroll, we need to roll it back to what he's been through. The sweet pup is in his 9th week of recovery since an IVDD (Intervertebral Disc Disease) flare-up. The neurological condition, as PetMD explains, is specific to "the spinal cord, vertebrae, or back bones, and the disc material between each vertebra," and occurs when "the cushioning discs between the bones of the spinal column either bulge or burst into the space containing the spinal cord." It's painful, causing nerve damage and even paralysis. The condition is more common among pups with long backs and short legs, like Oliver, who are prone to back injuries. His treatment plan has included crate and stroller rest, physical therapies, medical management with steroid injections, the use of a back sling to help with walking, acupuncture, laser therapy, and more. Getting a wheelchair gives Oliver the chance to take the walks he missed so much, even if he can't go as long or as far as he once did. Big Doxie brother, Frank, has been a great help, ever ready to lead the way on walk and in love."It's the ears flat back. Not a care in the world," one person wrote. "Lil baby is rolling hard," another added, while another joked, "Ears in 4x4, he is ready to go." He's come a long way, but it's his positive attitude that's lighting up the world. Oliver may still have a long road ahead of him but right now, things are starting to look up. Keep going, little man! 🐶🐾🐾
